Home › Parkinson's Disease › Connecticut › New Haven
Parkinson's Disease clinical trials in New Haven, CT
14 studies for Parkinson's Disease are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
RecruitingPhase 1Healthy volunteers welcome
- XingImaging LLC, New Haven
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
RecruitingPhase 2/3
- Site-028, New Haven
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
RecruitingPhase 2
- Yale University, New Haven
This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months.
RecruitingPhase 2Healthy volunteers welcome
- Institute for Neurodegenerative Disorders, New Haven
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
RecruitingObservational study
- Yale School of Medicine's Stephen and Denise Adams Center for Parkinson's Disease Research, New Haven
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
RecruitingPhase 3
- Institute for Neurodegenerative Disorders, New Haven
Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
RecruitingPhase 2Healthy volunteers welcome
- Institute for Neurodegenerative Disorders / XingImaging, LLC, New Haven
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
RecruitingObservational studyHealthy volunteers welcome
- Institute For Neurodegenerative Disorders, New Haven
Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies
RecruitingEarly phase 1Healthy volunteers welcome
- Institute for Neurodegenerative Disorders and XingImaging, LLC, New Haven
Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of [18F]MODAG-009 Positron Emission Tomography (PET) Radiotracers in Adult Healthy Volunteers
RecruitingEarly phase 1Healthy volunteers welcome
- Institute for Neurodegenerative Disorders and XingImaging, LLC, New Haven
Intestinal Immunity in Neurologic Disease
RecruitingObservational studyHealthy volunteers welcome
- Yale MS Clinic, North Haven · 7 mi away
Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
RecruitingEarly phase 1Healthy volunteers welcome
- Yale New Haven Hospital, New Haven
Imaging Depression in Parkinson's Disease
RecruitingPhase 2Healthy volunteers welcome
- Yale University, New Haven
Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder
RecruitingObservational study
- Digestive Disease Associates, Branford · 6 mi away
About Parkinson's Disease
Parkinson's disease (PD) is a movement disorder. It causes tremors, stiffness, and slow movement. It gets worse over time. Learn what can help.
More about Parkinson's Disease on MedlinePlus
Parkinson's Disease trials in other cities
- New York City, NY23 studies
- Boston, MA19 studies
- Cleveland, OH18 studies
- Minneapolis, MN17 studies
- Nashville, TN15 studies
- Philadelphia, PA14 studies
- San Francisco, CA14 studies
- Farmington Hills, MI13 studies
- Charleston, SC13 studies
- Chicago, IL13 studies
- Miami, FL13 studies
- Aurora, CO12 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer37 studies
- Cancer (all types)33 studies
- Metastatic Cancer23 studies
- Lung Cancer22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Ovarian Cancer21 studies
- Colorectal Cancer20 studies
- Prostate Cancer20 studies
- Opioid Overdose18 studies
- Alcohol Use Disorder (AUD)17 studies
- Acute Myeloid Leukemia17 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.